No Data
No Data
Express News | Nxera Pharma’s Partner Centessa Initiates Phase 2 Trial With Orx750, a Novel Orexin Receptor 2 (Ox2R) Agonist
Nxera Pharma Gains Milestone Payment in Sleep Disorder Collaboration
Stocks that moved on the previous day part2 include Japan Ham, Taiyo Koki, Fuji Kogaku E&C, etc.
Stock name <Code> 5-day closing price ⇒ Day-to-day comparison BIPROGY <8056> 4420 -3187- The 9-month period is expected to turn into a decrease in ordinary income. Nippon Ham <2282> 4754 -516 Negative sentiment such as sluggish improvement in processing business income. Tokyo Electron Devices <2760> 3065 -265 Half-year double-digit operating income decline results are also disappointing. Rigaku <268A> 1200 -50 Will selling pressure prevail due to awareness of resistance at the upper end? Nexera Pharma <4565> 1174 -397 -9
Express News | Nxera Pharma and Antiverse Enter Collaboration to Design Novel Gpcr-Targeted Antibody Therapeutics Using Generative AI
Nxera Pharma and Antiverse Enter Collaboration To Design Novel GPCR-Targeted Antibody Therapeutics Using Generative AI
Sumitomo Electric, Mabuchi, etc. (Additional) Rating
Upgrade - Bullish Code Stock Name Securities Company Previous After Change ---------------------------------- <6080> M&A Capcom Maclory "Under P" "Out P" <6752> Panasonic HD Maclory "Neutral" "Out P" Target Stock Price Change Code Stock Name Securities Company Previous After Change ----------------------------------
No Data
No Data